Macrovascular disease in a Japanese-Brazilian population of high prevalence of metabolic syndrome: Associations with classical and non-classical risk factors

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages 160-166

  Siqueira, Antonela F A ^a   Franco, Laercio J ^b   Gimeno, Suely G A ^a   Matsumura, Luiza K ^a   Abdalla, Dulcinéia S P ^b   de Barros Jr , Newton ^b   Ferreira, Sandra R G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti LDL antibodies; Cardiovascular risk factors; Japanese Brazilians; Macrovascular disease; Metabolic syndrome

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN ANTIBODY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BRAZIL; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE URINE LEVEL; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; JAPANESE; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN URINE LEVEL; RISK; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; WAIST HIP RATIO;

ADULT; AGED; BRAZIL; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 35248871996     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.09.012     Document Type: Article

References (30)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-151
2. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
3. Fujimoto W.Y., Bergstrom R.W., Boyko E.J., et al. Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diab Res Clin Pract 24 Suppl (1994) S43-52
4. Ferreira S.R.G., Iunes M., Franco L.J., Iochida L.C., Hirai A., and Vivolo M.A. Disturbances of glucose and lipid metabolism in first and second generation Japanese-Brazilians. Diabetes Res Clin Pract 34 Suppl. (1996) S59-63
5. Gimeno S.G., Ferreira S.R.G., Franco L.J., Hirai A.T., Matsumura L., and Moises R.S. Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45 (2002) 1635-1638
6. Rosenbaum P., Gimeno S.G., Sanudo A., Franco L.J., and Ferreira S.R.G. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians. Diabetes Obes Metab 7 (2005) 352-359
7. Gimeno S.G., Osiro K., Matsumura L., Massimino F.C., and Ferreira S.R.G. Glucose intolerance and all-cause mortality in Japanese migrants. Diab Res Clin Pract 68 (2005) 147-154
8. Sytkowski P.A., Kannel W.B., and D'Agostino R.B. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 322 (1990) 1635-1641
9. Kannel W.B., and McGee D.L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59 (1979) 8-13
10. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diab Med 23 (2006) 469-480
11. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 15 (1998) 539-553
12. Baker J.F., Krishnan E., Chen L., and Schumacher H.R. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med 118 (2005) 816-826
13. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
14. Soinio M., Marniemi J., Laakso M., Lehto S., and Ronnemaa T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 140 (2004) 94-100
15. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
16. Lopes-Virella M.F., and Virella G. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 73 (1994) 155-167
17. Avogaro P., Bon G.B., and Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8 (1988) 79-87
18. Shoenfeld Y., Wu R., Dearing L.D., and Matsuura E. Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?. Circulation 110 (2004) 2552-2558
19. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
20. Pfeiffer C.M., Huff D.L., and Gunter E.W. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45 (1999) 290-292
21. Oliveira J.A., Sevanian A., Rodrigues R.J., Apolinario E., and Abdalla D.S.P. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clin Biochem 39 (2006) 708-714
22. The Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
23. Steering Committee of the Western Pacific Region of the World Health Organization. The International Obesity Task Force (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia: Health Communications Australia Pty Limited. (retrieved from http://www.diabetes.com.au/pdf/obesity_report.pdf) (Acessed 03 July 2006).
24. Zheng Z.J., Sharrett A.R., Chambless L.E., et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 131 (1997) 115-125
25. Marmot M.G., Syme S.L., Kagan A., Kato H., Cohen J.B., and Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 102 (1975) 514-525
26. Siqueira A.F.A., Gimeno S.G.A., Hirai A.T., Franco L.J., and Ferreira S.R.G. Marcante prevalência de dislipidemia em população nipo-brasileira de Bauru. Arq Bras Endocrinol Metab 50 Suppl 2 (2006) S174. (in Portuguese)
27. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
28. Karalliedde J., and Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 17 (2004) 986-993
29. Rosenbaum P., Gimeno S.G., Sanudo A., Franco L.J., and Ferreira S.R.G. Independent impact of glycemia and blood pressure in albuminuria on high-risk subjects for metabolic syndrome. Clin Nephrol 61 (2004) 369-376
30. Piarulli F., Lapolla A., Sartore G., et al. Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes. Diab Care 28 (2005) 653-657